Congratulations to our members Dr Camelia Quek and Dr Tuba Nur Gide for receiving 2021 Cancer Institute NSW Early Career Fellowships.
Dr Camelia Quek was awarded the 2021 Early Career Fellowship and will receive $533,558 in funding for her project Dissecting novel immunotherapeutic resistance and progression in advanced melanoma. Dr Quek completed a PhD in Genomics and Bioinformatics at the University of Melbourne and is currently a postdoctoral researcher at the Melanoma Institute Australia. Her work focuses on clinicopathological determinants of risk, disease progression and drug-treatment response in melanoma.
Dr Tuba Nur Gide was awarded the 2021 Early Career Fellowship and will receive $574,334 in funding for her project Clinical implementation of the Personalised Immunotherapy Platform as a comprehensive predictive tool to inform the drug treatment of advanced cancer patients. Dr Gide is a postdoctoral researcher at the Melanoma Institute Australia. She completed her PhD at the University of Sydney in 2019, focusing on the identification of biomarkers of response and resistance to anti-PD-1 based immunotherapies in metastatic melanoma.
To find out more, click here.